From batch to continuous chromatographic purification of a therapeutic peptide through multicolumn countercurrent solvent gradient purification.
Continuous chromatography
Multicolumn countercurrent solvent gradient process
Peptide purification
Preparative chromatography
Journal
Journal of chromatography. A
ISSN: 1873-3778
Titre abrégé: J Chromatogr A
Pays: Netherlands
ID NLM: 9318488
Informations de publication
Date de publication:
16 Aug 2020
16 Aug 2020
Historique:
received:
27
03
2020
revised:
27
05
2020
accepted:
01
06
2020
entrez:
26
7
2020
pubmed:
28
7
2020
medline:
4
9
2020
Statut:
ppublish
Résumé
A twin-column Multicolumn Countercurrent Solvent Gradient Purification (MCSGP) process has been developed for the purification of a therapeutic peptide, glucagon, from a crude synthetic mixture. This semi-continuous process uses two identical columns operating either in interconnected or in batch mode, thus enabling the internal recycle of the portions of the eluting stream which do not comply with purity specifications. Because of this feature, which actually results in the simulated countercurrent movement of the stationary phase with respect to the mobile one, the yield-purity trade-off typical of traditional batch preparative chromatography can be alleviated. Moreover, the purification process can be completely automatized. Aim of this work is to present a simple procedure for the development of the MCSGP process based on a single batch experiment, in the case of a therapeutic peptide of industrial relevance. This allowed to recover roughly 90% of the injected glucagon in a purified pool with a purity of about 90%. A comparison between the performance of the MCSGP process and the classical single column batch process indicates that percentage increase in the recovery of target product is +23% when transferring the method from batch conditions to MCSGP, with an unchanged purity of around 89%. This improvement comes at the expenses of a reduction of about 38% in productivity.
Identifiants
pubmed: 32709347
pii: S0021-9673(20)30582-3
doi: 10.1016/j.chroma.2020.461304
pii:
doi:
Substances chimiques
Peptides
0
Solvents
0
Glucagon
9007-92-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
461304Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.